Cite
Evaluation of 2-methoxyestradiol serum levels as a potential prognostic marker in malignant melanoma
MLA
Frank Louwen, et al. “Evaluation of 2-Methoxyestradiol Serum Levels as a Potential Prognostic Marker in Malignant Melanoma.” Molecular and Clinical Oncology, vol. 15, no. 1, July 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a5fb453f16266af66d0f8f7f3028680&authtype=sso&custid=ns315887.
APA
Frank Louwen, Nadja Zoeller, Johannes Kleemann, Igor Hrgovic, Florian Weid, Stefan Kippenberger, Roland Kaufmann, Monika Doll, Carmen Loquai, & Markus Meissner. (2020). Evaluation of 2-methoxyestradiol serum levels as a potential prognostic marker in malignant melanoma. Molecular and Clinical Oncology, 15(1).
Chicago
Frank Louwen, Nadja Zoeller, Johannes Kleemann, Igor Hrgovic, Florian Weid, Stefan Kippenberger, Roland Kaufmann, Monika Doll, Carmen Loquai, and Markus Meissner. 2020. “Evaluation of 2-Methoxyestradiol Serum Levels as a Potential Prognostic Marker in Malignant Melanoma.” Molecular and Clinical Oncology 15 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7a5fb453f16266af66d0f8f7f3028680&authtype=sso&custid=ns315887.